VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ANIP
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ANIPANI Pharmaceuticals, Inc.
$85.99$2.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksANIPQuarterly Financials

ANI Pharmaceuticals, Inc. (ANIP) Quarterly Financials

120+ quarters historyFree accessUpdated daily

ANI Pharmaceuticals, Inc. (ANIP) quarterly income statement — complete revenue, gross profit & net income history

ANIP Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue237.46M247.06M227.81M211.37M197.12M190.57M148.33M138.04M137.43M131.65M131.83M116.55M106.79M94.23M83.82M73.86M64.48M60.93M52.06M48.63M
Revenue Growth %20.46%29.64%53.58%53.12%43.43%44.75%12.52%18.44%28.7%39.71%57.27%57.81%65.62%54.66%61.01%51.89%18.26%6.42%-1.73%0.32%
Cost of Goods Sold114.5M9.5M116.02M74.61M73.04M80.28M63.08M57.7M49.16M53.42M48.1M42.28M37.71M36.33M32.89M35.29M34.27M33.9M24.41M22.31M
COGS % of Revenue48.22%3.85%50.93%35.3%37.05%42.13%42.52%41.8%35.77%40.58%36.49%36.28%35.31%38.55%39.24%47.79%53.15%55.64%46.89%45.89%
Gross Profit122.96M237.56M111.79M136.76M124.08M110.29M85.26M80.34M88.27M78.23M83.73M74.26M69.08M57.91M50.93M38.56M30.21M27.03M27.65M26.31M
Gross Margin %51.78%96.15%49.07%64.7%62.95%57.87%57.48%58.2%64.23%59.42%63.51%63.72%64.69%61.45%60.76%52.21%46.85%44.36%53.11%54.11%
Gross Profit Growth %-0.91%115.39%31.12%70.22%40.57%40.98%1.83%8.19%27.79%35.11%64.41%92.59%128.69%114.22%84.2%46.56%-12.54%-17.37%-15.86%-5.27%
Operating Expenses84.25M189.38M88.96M122.86M97.89M114.67M105.78M75.17M67.96M71.51M65.78M61.86M59.18M56.09M55.92M51.47M49.4M50.75M31.21M41.86M
OpEx % of Revenue35.48%76.66%39.05%58.13%49.66%60.17%71.31%54.46%49.45%54.32%49.9%53.08%55.42%59.52%66.72%69.7%76.62%83.3%59.95%86.1%
Selling, General & Admin73.66M82.79M76.66M81.77M76.53M69.72M79.08M52.82M48.02M44.46M42.01M38.76M36.47M33.19M30.08M31.96M28.82M30.71M17.18M18.82M
SG&A % of Revenue31.02%33.51%33.65%38.69%38.82%36.58%53.31%38.27%34.94%33.77%31.86%33.26%34.15%35.22%35.89%43.27%44.69%50.4%33%38.7%
Research & Development10.6M12.26M12.3M16.54M10.56M16.65M10.13M7.3M10.51M9.87M11.12M7.37M5.92M5.22M7.66M4.17M5.27M3.14M2.46M2.81M
R&D % of Revenue4.46%4.96%5.4%7.82%5.36%8.73%6.83%5.29%7.65%7.49%8.44%6.33%5.55%5.54%9.13%5.64%8.18%5.15%4.72%5.77%
Other Operating Expenses01000K01000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Operating Income38.71M48.17M22.83M13.89M26.19M-4.38M-20.52M5.17M20.31M6.73M17.95M12.4M9.89M1.82M-5M-12.91M-19.2M-23.72M-3.56M-15.55M
Operating Margin %16.3%19.5%10.02%6.57%13.29%-2.3%-13.83%3.74%14.78%5.11%13.61%10.64%9.27%1.93%-5.96%-17.48%-29.77%-38.94%-6.84%-31.99%
Operating Income Growth %47.77%1200.39%211.27%168.76%28.96%-165.09%-214.32%-58.32%105.28%269.56%459.32%196.04%151.55%107.67%-40.23%16.97%-730.38%-7267.07%-227.12%-37.55%
EBITDA59.63M70.79M45.46M37.17M49.09M18.22M-4.77M19.87M35M21.92M33.16M27.09M24.59M17.39M10.36M1.26M-4.64M-10.04M7.78M-4.23M
EBITDA Margin %25.11%28.65%19.96%17.59%24.9%9.56%-3.22%14.39%25.47%16.65%25.15%23.25%23.03%18.46%12.35%1.71%-7.19%-16.48%14.95%-8.7%
EBITDA Growth %21.47%288.48%1052.92%87.12%40.25%-16.87%-114.39%-26.67%42.3%26.04%220.18%2048.45%630.29%273.24%33.03%129.82%-133.26%-189.39%-45.03%-3779.82%
D&A (Non-Cash Add-back)20.92M22.61M22.63M23.28M22.89M22.6M15.75M14.7M14.69M15.19M15.21M14.69M14.7M15.57M15.35M14.17M14.56M13.68M11.35M11.32M
EBIT38.71M54.32M38.53M15.96M25.47M-7.75M-29.17M2.37M29.93M6.69M17.91M12.35M9.86M1.78M-4.96M-12.15M-19.28M-26.41M-4.63M-15.62M
Net Interest Income3.77M-17.43M-4.73M-5.44M-5.48M-6.01M-2.33M-4.66M-4.6M-5.75M-6.4M-7.1M-7.7M-7.51M-7.26M-6.67M-6.61M-4.44M-2.5M-2.53M
Interest Income05.41M02.78M2.62M000000000000000
Interest Expense-3.77M22.84M4.73M8.22M8.11M6.01M2.33M4.66M4.6M5.75M6.4M7.1M7.7M7.51M7.26M6.67M6.61M4.44M2.5M2.53M
Other Income/Expense1.51M-16.7M10.97M-3.37M-6.21M-9.38M-10.98M-7.46M5.02M-5.78M-6.44M-7.15M-7.73M-7.55M-7.23M-5.91M-6.7M-7.13M-3.57M-2.6M
Pretax Income40.22M31.48M33.8M10.53M19.99M-13.76M-31.5M-2.29M25.34M947K11.51M5.25M2.17M-5.73M-12.22M-18.82M-25.9M-30.85M-7.13M-18.15M
Pretax Margin %16.94%12.74%14.84%4.98%10.14%-7.22%-21.23%-1.66%18.43%0.72%8.73%4.5%2.03%-6.08%-14.58%-25.48%-40.16%-50.64%-13.7%-37.33%
Income Tax10.73M3.99M7.18M1.98M4.31M-3.49M-7.33M07.13M-208K1.57M-996K726K-1.49M-3.62M-3.9M-5.77M-6.72M-2.68M-4.04M
Effective Tax Rate %26.68%12.67%21.25%18.77%21.54%25.33%23.28%0%28.13%-21.96%13.65%-18.98%33.53%25.93%29.64%20.7%22.27%21.77%37.63%22.29%
Net Income29.49M27.49M24.13M8.55M15.68M-10.28M-24.17M-2.29M18.21M1.16M9.94M6.25M1.44M-4.24M-8.6M-14.92M-20.13M-24.14M-4.45M-14.11M
Net Margin %12.42%11.13%10.59%4.04%7.95%-5.39%-16.29%-1.66%13.25%0.88%7.54%5.36%1.35%-4.5%-10.26%-20.21%-31.22%-39.61%-8.54%-29.01%
Net Income Growth %88.07%367.52%199.87%473.81%-13.87%-989.7%-343.12%-136.62%1165.25%127.22%215.58%141.85%107.15%82.42%-93.39%-5.79%-23506.98%-563.99%-1124.65%-14.35%
Net Income (Continuing)29.49M27.49M26.62M8.55M15.68M-10.28M-24.17M-2.29M18.21M1.16M9.94M6.25M1.44M-4.24M-8.6M-14.92M-20.13M-24.14M-4.45M-14.11M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)1.281.171.130.360.69-0.55-1.27-0.140.830.040.500.330.06-0.28-0.53-0.92-1.25-1.70-0.37-1.17
EPS Growth %85.51%312.73%188.98%357.14%-16.87%-1510.26%-354%-142.42%1228%113.93%194.34%135.87%105%83.53%-43.24%21.37%-12600%-466.67%-1025%-13.59%
EPS (Basic)1.311.241.190.370.70-0.55-1.27-0.140.840.040.500.330.06-0.28-0.53-0.92-1.25-1.70-0.37-1.17
Diluted Shares Outstanding21.54M21.23M21.09M20.31M20.05M19.45M19.4M19.32M19.42M19.22M19.13M17.86M16.53M16.32M16.3M16.27M16.14M14.19M12.11M12.09M
Basic Shares Outstanding20.91M20.05M20.07M19.83M19.61M19.45M19.4M19.32M19.1M19M18.88M17.69M16.39M16.32M16.3M16.27M16.14M14.17M12.02M12.06M
Dividend Payout Ratio--------------------